Multiple Ascending Dose (MDX1105-01)

Clinical trial NCT00729664 · COMPLETED

Trial details

NCT number: NCT00729664
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer, Multiple Indications

Start date: 2009-02-01
Primary completion: 2015-07-01
Enrollment: 281

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.